Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic’s Restore, W.L. Gore’s Tag Receive New Tech Add-On Payment

This article was originally published in The Gray Sheet

Executive Summary

Medtronic's argument that the Restore rechargeable implantable neurostimulator represents a substantial clinical improvement over existing devices convinced CMS to award the device new technology add-on payment for fiscal year 2007

You may also be interested in...



CMS New Tech Town Hall: Industry Insists Bonus Threshold Is Too High

Boston Scientific's Wingspan intracranial stent is the only product under consideration for a new technology add-on payment in fiscal year 2008, prompting stakeholders to complain that the opaqueness of CMS' criteria for awarding the bonus payment has deterred most firms from even applying

CMS New Tech Town Hall: Industry Insists Bonus Threshold Is Too High

Boston Scientific's Wingspan intracranial stent is the only product under consideration for a new technology add-on payment in fiscal year 2008, prompting stakeholders to complain that the opaqueness of CMS' criteria for awarding the bonus payment has deterred most firms from even applying

Placebo Effect Hinders Quality Of Chronic Pain Treatment Trials – FDA, CMS

Chronic pain therapy manufacturers must meet challenges presented by the placebo effect when designing clinical trials, according to FDA and CMS

Related Content

UsernamePublicRestriction

Register

OM007016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel